DLC1 antibody (N-Term)

Catalog No. ABIN7188694

Product Details anti-DLC1 Antibody

Target: DLC1 (Deleted in Liver Cancer 1 (DLC1))

Binding Specificity: N-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This DLC1 antibody is un-conjugated

Application: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Cross-Reactivity: Human, Mouse, Rat

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen: Synthesized peptide derived from the N-terminal region of Human DLC-1.

Isotype: IgG

Application Details

Application Notes: IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for DLC1

Target: DLC1 (Deleted in Liver Cancer 1 (DLC1))

Alternative Name: DLC1 (DLC1 Products)

Background: ARHGAP 7 antibody, ARHGAP7 antibody, Deleted in liver cancer 1 antibody, Deleted in liver cancer 1 protein antibody, DLC 1 antibody, Dlc-1 antibody, DLC1 antibody, DLC1 Rho GTPase activating protein antibody, FLJ21120 antibody, HP antibody, HP protein antibody, KIAA1723 antibody, p122 RhoGAP antibody, RHG07_HUMAN antibody, Rho GTPase activating protein 7 antibody, Rho GTPase-activating protein 7 antibody, Rho type GTPase activating protein 7 antibody, Rho-type GTPase-activating protein 7 antibody, StAR related lipid transfer (START) domain containing 12 antibody, StAR related lipid transfer protein 12 antibody, StAR-related lipid transfer protein 12 antibody, STARD 12 antibody, StARD12 antibody, START domain containing protein 12 antibody, START domain-containing protein 12 antibody

UniProt: Q96QB1

Pathways: Tube Formation, Positive Regulation of Endopeptidase Activity